Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Kin Chow

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biotechnology Progress|April 3, 2004
Enzyme encapsulation in permeabilized Saccharomyces cerevisiae cellsChi-Kin Chow, Sean P Palecek
BMC Bioinformatics|May 13, 2010
Error margin analysis for feature gene extractionChi Kin Chow, Hai Long Zhu, Jessica Lacy, et al.
Molecular Pharmaceutics|February 6, 2016
Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal StructureChi-Kin Chow, Barrett W Allan, Qing Chai, et al.
Molecular Pharmaceutics|February 7, 2013
Rapid analysis of antibody self-association in complex mixtures using immunogold conjugatesShantanu V Sule, Craig D Dickinson, Jirong Lu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2012
FcRn affinity-pharmacokinetic relationship of five human IgG4 antibodies engineered for improved in vitro FcRn binding properties in cynomolgus monkeysAmita Datta-Mannan, Chi-Kin Chow, Craig Dickinson, et al.
Journal of Inflammation Research|May 5, 2016
Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17ALing Liu, Jirong Lu, Barrett W Allan, et al.
Mabs|June 12, 2019
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune diseaseRobert J Benschop, Chi-Kin Chow, Yu Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growthLing Liu, Wei Zeng, Mark A Wortinger, et al.
Histopathology|July 22, 2014
Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET)Aaron M Gruver, Ling Liu, Peter Vaillancourt, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biotechnology Progress|April 3, 2004
Enzyme encapsulation in permeabilized Saccharomyces cerevisiae cellsChi-Kin Chow, Sean P Palecek
BMC Bioinformatics|May 13, 2010
Error margin analysis for feature gene extractionChi Kin Chow, Hai Long Zhu, Jessica Lacy, et al.
Molecular Pharmaceutics|February 6, 2016
Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal StructureChi-Kin Chow, Barrett W Allan, Qing Chai, et al.
Molecular Pharmaceutics|February 7, 2013
Rapid analysis of antibody self-association in complex mixtures using immunogold conjugatesShantanu V Sule, Craig D Dickinson, Jirong Lu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2012
FcRn affinity-pharmacokinetic relationship of five human IgG4 antibodies engineered for improved in vitro FcRn binding properties in cynomolgus monkeysAmita Datta-Mannan, Chi-Kin Chow, Craig Dickinson, et al.
Journal of Inflammation Research|May 5, 2016
Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17ALing Liu, Jirong Lu, Barrett W Allan, et al.
Mabs|June 12, 2019
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune diseaseRobert J Benschop, Chi-Kin Chow, Yu Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growthLing Liu, Wei Zeng, Mark A Wortinger, et al.
Histopathology|July 22, 2014
Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET)Aaron M Gruver, Ling Liu, Peter Vaillancourt, et al.
Pageof 1